Decreased Fibrinolysis
- Name
- Decreased Fibrinolysis
- Accession Number
- DBCAT004136
- Description
Not Available
- Drugs
Drug Drug Description Aminocaproic acid An antifibrinolytic agent used to induce clotting postoperatively. Tranexamic acid An antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders. Aprotinin A serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery. - Drugs & Drug Targets
Drug Target Type Aminocaproic acid Plasminogen target Aminocaproic acid Tissue-type plasminogen activator target Aminocaproic acid Apolipoprotein(a) target Aminocaproic acid Aldehyde oxidase enzyme Tranexamic acid Plasminogen target Aprotinin Trypsin-1 target Aprotinin Chymotrypsinogen B target Aprotinin Plasminogen target Aprotinin Kallikrein-1 target Aprotinin Cholinesterase enzyme